目的:为我国药品医保谈判机制的进一步完善提供参考.方法:对参与江苏省、江西省、青岛市、成都市四地药品医保谈判的部分医保经办机构和医药企业工作人员进行问卷调查,了解其业务熟悉情况和对谈判机制的认可程度,并采用描述性分析、独立样本t检验分析等方法对数据进行统计和分析.结果:共发放问卷70份,回收有效问卷68份,有效回收率为97.14%;包括医保经办机构受访者21人,医药企业受访者47人.对于业务熟悉情况,受访者各方面评分平均值均>3(4分制),以"药品谈判项目执行过程中的管理方式"评分最低;两类受访者在"药品谈判过程应遵循的基本原则""实质性谈判过程中的谈判目标""业务熟悉情况总评分"方面的评分比较差异均有统计学意义(P4.两类受访者对谈判机制整体效果、谈判准备工作、谈判项目监管评估情况的认可程度各方面评分比较差异均无统计学意义(P>0.05);而对实质性谈判工作的认可程度在"谈判过程中双方在平等、合作、融洽的氛围下进行谈判"方面的评分比较差异有统计学意义(P4 except for"patients taking drugs is quick and easy". There was no statistical significance between 2 types of respondents in all aspects of overall effect of the negotiation mechanism, preparation of the negotiations and negotiation project's supervision and evaluation(P>0.05). But in the recognition of the substan-tive negotiation,there was statistically significance between 2 types of respondents in"negotiations between the two sides in an equal,cooperative,harmonious atmosphere"(P<0.05). Healthcare agencies'respondents had higher scores than pharmaceutical companies'ones. And in the recognition of the implementation of the negotiation agreement,there was statistical significance be-tween 2 types of respondents in the"after the agreement entered into force,the medical insurance agency will be strictly in accor-dance with the agreement"and"fund pay to pharmaceutical companies timely and reasonable"(P≤0.05). Healthcare agencies're-spondents have higher scores for than pharmaceutical companies'ones. CONCLUSIONS:The current drug medical insurance nego-tiation mechanism shows good overall effect and runs smoothly. But there are still some shortages,such as collected information the preparation stage is not sufficient;the procedures of patients taking the drug is complicated;negotiating parties do not have equal status;the fund is not paid to the pharmaceutical enterprise timely;evaluation is not perfect.
展开▼
